PrecisionLife participated in a conversation with Chris Armstrong discussing ME/CFS and long COVID research highlighted by Open Medicine Foundation.

We're addressing one of the greatest challenges of our time - transforming healthcare to predict, treat, and prevent the world's most costly diseases. Chronic diseases are the biggest challenge facing global health. Billions of people live with debilitating conditions that are misunderstood, misdiagnosed, and mistreated - crippling healthcare systems, limiting quality of life, and costing trillions of dollars around the world. PrecisionLife is here to change that. We've developed the world's leading AI and genetic analysis platform on the planet to decipher the biological drivers of complex conditions and solve chronic disease. Our analytics platform reveals the unique biological mechanisms that cause disease and the biology that can protect people. This lets us: • Develop low-cost, non-invasive tests that can predict diseases earlier and with greater accuracy • Help doctors match patients to the most effective treatments and specialisms based on their personal biology • Support pharmaceutical companies to develop more targeted therapies and clinical trials with greater probability of success • Develop personalized healthcare solutions to prevent chronic diseases Our approach is groundbreaking and already helping to tackle 60+ diseases across neuroscience, women's health, cardiovascular disease and immunology. We’ve created the world’s largest repository of chronic disease insights and IP, and are working with partners across healthcare and industry to bring truly personalized medicine to patients - improving lives and reducing the unsustainable pressure on health systems. Our mission is bold but simple: To give every patient a faster, clearer path to better health – creating more personalized treatment options and diagnostic tools to reduce the global burden of chronic disease through precision medicine that works for everyone.